These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35686837)

  • 1. Active Surveillance versus Immediate Intervention for Small Renal Masses: A Cost-Effectiveness and Clinical Decision Analysis.
    Su ZT; Patel HD; Huang MM; Alam R; Cheaib JG; Pavlovich CP; Allaf ME; Pierorazio PM
    J Urol; 2022 Oct; 208(4):794-803. PubMed ID: 35686837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness Analysis of
    Su ZT; Patel HD; Huang MM; Meyer AR; Pavlovich CP; Pierorazio PM; Javadi MS; Allaf ME; Rowe SP; Gorin MA
    Eur Urol Focus; 2021 Jul; 7(4):827-834. PubMed ID: 32115400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis: percutaneous microwave ablation vs robotic-assisted partial nephrectomy for small renal masses.
    Yeaman C; Marchant R; Lobo JM; DeNovio A; O'Connor L; Wanchek T; Ballantyne C; Lambert DL; Mithqal A; Schenkman N
    Abdom Radiol (NY); 2023 Jan; 48(1):411-417. PubMed ID: 36210369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy.
    Patel N; Cranston D; Akhtar MZ; George C; Jones A; Leiblich A; Protheroe A; Sullivan M
    BJU Int; 2012 Nov; 110(9):1270-5. PubMed ID: 22564495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness Analysis Comparing Biopsy in Advance of Ablation with Concurrent Biopsy and Ablation for Small Renal Masses Measuring 1-3 cm.
    Florea A; Zaric GS; Kang Z; Cool DW
    J Vasc Interv Radiol; 2024 Sep; 35(9):1388-1396.e5. PubMed ID: 38759884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary management of small renal masses: does practice environment matter?
    Smith PH; Elliott VL; Raman JD
    Can J Urol; 2012 Oct; 19(5):6438-42. PubMed ID: 23040625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the best treatment strategy for incidentally detected small renal masses? A decision analysis.
    Abouassaly R; Yang S; Finelli A; Kulkarni GS; Alibhai SM
    BJU Int; 2011 Oct; 108(8 Pt 2):E223-31. PubMed ID: 21569190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-utility analysis of radical nephrectomy versus partial nephrectomy in the management of small renal masses: Adjusting for the burden of ensuing chronic kidney disease.
    Klinghoffer Z; Tarride JE; Novara G; Ficarra V; Kapoor A; Shayegan B; Braga LH
    Can Urol Assoc J; 2013; 7(3-4):108-13. PubMed ID: 23671525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of Management Options for Small Renal Mass: A Systematic Review.
    Wang Y; Chen YW; Leow JJ; Levy AC; Chang SL; Gelpi FH
    Am J Clin Oncol; 2016 Oct; 39(5):484-90. PubMed ID: 27322701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis.
    Pandharipande PV; Gervais DA; Mueller PR; Hur C; Gazelle GS
    Radiology; 2008 Jul; 248(1):169-78. PubMed ID: 18458248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid lobectomy as a cost-effective approach in low-risk papillary thyroid cancer versus active surveillance.
    Youssef MR; Attia AS; Omar M; Aboueisha M; Freeman MN; Shama M; Kandil E
    Surgery; 2022 Jan; 171(1):190-196. PubMed ID: 34384606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary management of small renal masses.
    Volpe A; Cadeddu JA; Cestari A; Gill IS; Jewett MA; Joniau S; Kirkali Z; Marberger M; Patard JJ; Staehler M; Uzzo RG
    Eur Urol; 2011 Sep; 60(3):501-15. PubMed ID: 21664040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of management options for patients with small renal masses: a prospective cohort study.
    Alam R; Patel HD; Osumah T; Srivastava A; Gorin MA; Johnson MH; Trock BJ; Chang P; Wagner AA; McKiernan JM; Allaf ME; Pierorazio PM
    BJU Int; 2019 Jan; 123(1):42-50. PubMed ID: 30019484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of nephron sparing options for the management of small renal masses.
    Chang SL; Cipriano LE; Harshman LC; Garber AM; Chung BI
    J Urol; 2011 May; 185(5):1591-7. PubMed ID: 21419445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active surveillance, radiofrequency ablation, or cryoablation for the nonsurgical management of a small renal mass: a cost-utility analysis.
    Bhan SN; Pautler SE; Shayegan B; Voss MD; Goeree RA; You JJ
    Ann Surg Oncol; 2013 Oct; 20(11):3675-84. PubMed ID: 23720071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness, costs and trends in treatment of small renal masses from 2005 to 2007.
    Kowalczyk KJ; Choueiri TK; Hevelone ND; Trinh QD; Lipsitz SR; Nguyen PL; Lynch JH; Hu JC
    BJU Int; 2013 Aug; 112(4):E273-80. PubMed ID: 23452093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry.
    Pierorazio PM; Johnson MH; Ball MW; Gorin MA; Trock BJ; Chang P; Wagner AA; McKiernan JM; Allaf ME
    Eur Urol; 2015 Sep; 68(3):408-15. PubMed ID: 25698065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Effectiveness of Surgical Treatments for Small Renal Masses.
    Agrawal S; Sedlacek H; Kim SP
    Urol Clin North Am; 2017 May; 44(2):257-267. PubMed ID: 28411917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of delayed resection after initial surveillance and tumor growth rate on final surgical pathology in patients with small renal masses (SRMs).
    Hawken SR; Krishnan NK; Ambani SN; Montgomery JS; Caoili EM; Ellis JH; Kunju LP; Hafez KS; Miller DC; Kutikov A; Palapattu GS; Weizer AZ; Stuart Wolf J; Morgan TM
    Urol Oncol; 2016 Nov; 34(11):486.e9-486.e15. PubMed ID: 27687544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.